CME Group Inc. $CME Stock Purchased by Ilmarinen Mutual Pension Insurance Co

Ilmarinen Mutual Pension Insurance Co raised its position in CME Group Inc. (NASDAQ:CME – Free Report) by 29.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 94,238 shares of the financial services provider’s stock after purchasing an additional 21,627 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in CME Group were worth $24,688,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CME. BlackRock Inc. acquired a new position in CME Group in the 2nd quarter worth about $6,749,965,000. Bank of New York Mellon Corp purchased a new stake in shares of CME Group during the 2nd quarter worth about $867,313,000. Alphabet Inc. acquired a new stake in shares of CME Group during the 2nd quarter valued at about $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of CME Group during the 2nd quarter valued at about $629,771,000. Finally, Bank of America Corp DE acquired a new stake in shares of CME Group during the 2nd quarter valued at about $622,679,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group News Roundup

Investors following CME have been watching these news items:

  • Positive Sentiment: The company announced the first trade in its wind power contracts, extending its product lineup and potentially opening another market for trading and risk management. Article
  • Neutral Sentiment: A report highlights exchange operators’ potential exposure to AI-driven trading, but provides no specific new CME business or financial update. Article
  • Negative Sentiment: CEO Terrence Duffy sold 27,000 shares, reducing his direct holdings by about 43%; General Counsel John Marchese also sold 655 shares. Insider sales can be for personal reasons and do not necessarily signal weaker prospects, but may weigh on sentiment. CEO sale report General counsel sale report

CME Group Trading Up 0.4%

CME Group stock opened at $307.54 on Friday. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company’s fifty day moving average price is $289.43 and its two-hundred day moving average price is $282.08. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $110.08 billion, a price-to-earnings ratio of 25.23, a PEG ratio of 3.90 and a beta of 0.15.

CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The business’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.68 earnings per share. On average, analysts forecast that CME Group Inc. will post 12.36 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, December 11th. CME Group’s dividend payout ratio (DPR) is presently 42.66%.

Insiders Place Their Bets

In other CME Group news, insider Julie Winkler sold 10,079 shares of the company’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total transaction of $3,075,606.85. Following the completion of the sale, the insider owned 21,482 shares of the company’s stock, valued at $6,555,232.30. This represents a 31.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sunil Cutinho sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total value of $1,493,500.00. Following the sale, the insider directly owned 20,037 shares of the company’s stock, valued at $5,985,051.90. The trade was a 19.97% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 61,166 shares of company stock worth $18,276,512 in the last three months. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on CME shares. Deutsche Bank cut CME Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. Morgan Stanley increased their price objective on CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Piper Sandler reaffirmed an “overweight” rating and set a $330.00 price objective (up from $295.00) on shares of CME Group in a research report on Thursday, October 22nd. CLSA set a $367.00 target price on shares of CME Group in a research note on Thursday, October 22nd. Finally, Barclays lifted their target price on shares of CME Group from $281.00 to $321.00 and gave the company an “equal weight” rating in a research note on Thursday, October 22nd. Ten equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $314.44.

Check Out Our Latest Stock Analysis on CME Group

CME Group Company Profile

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Recommended Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.